What is Evommune, Inc.'s Market Cap?

Evommune, Inc.'s Market Cap is $185.1M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Enterprise Value?

Evommune, Inc.'s Enterprise Value is -$14.8M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Price / Sales?

Evommune, Inc.'s Price / Sales is 18.5×, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EV / Revenue?

Evommune, Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EV / EBITDA?

Evommune, Inc.'s EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Revenue (TTM)?

Evommune, Inc.'s Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Net Income (TTM)?

Evommune, Inc.'s Net Income (TTM) is -$94.7M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EBITDA?

Evommune, Inc.'s EBITDA is -$101.3M, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s Diluted EPS (TTM)?

Evommune, Inc.'s Diluted EPS (TTM) is -2.61, based on as-reported figures from SEC (XBRL) filings.

What is Evommune, Inc.'s EBITDA Margin?

Evommune, Inc.'s EBITDA Margin is -1012.9%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Evommune, Inc.

XNYS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Y79N8B3

5.10▼ 0.11 (-2.11%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 5.21
Day's Range: 4.94 – 5.18
52-Week Range: 4.94 – 33.25
Volume: 280.5K
Avg Volume: 768.8K

Share Statistics

Shares Outstanding
Employees: 48
Exchange: XNYS
Listed: 2025-11-06

Share count as of August 4, 2026

Evommune, Inc. (EVMN) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Evommune, Inc. (EVMN)

What is Evommune, Inc.'s Market Cap?: Evommune, Inc.'s Market Cap is $185.1M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Enterprise Value?: Evommune, Inc.'s Enterprise Value is -$14.8M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Price / Sales?: Evommune, Inc.'s Price / Sales is 18.5×, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EV / Revenue?: Evommune, Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EV / EBITDA?: Evommune, Inc.'s EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Revenue (TTM)?: Evommune, Inc.'s Revenue (TTM) is $10.0M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Net Income (TTM)?: Evommune, Inc.'s Net Income (TTM) is -$94.7M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EBITDA?: Evommune, Inc.'s EBITDA is -$101.3M, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s Diluted EPS (TTM)?: Evommune, Inc.'s Diluted EPS (TTM) is -2.61, based on as-reported figures from SEC (XBRL) filings.
What is Evommune, Inc.'s EBITDA Margin?: Evommune, Inc.'s EBITDA Margin is -1012.9%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · EVMNAs-filed SEC (XBRL) data